Agammaglobulinemia: causative mutations and their implications for novel therapies
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Agammaglobulinemia: causative mutations and their implications for novel therapies
Authors
Keywords
-
Journal
Expert Review of Clinical Immunology
Volume 9, Issue 12, Pages 1205-1221
Publisher
Informa UK Limited
Online
2013-11-12
DOI
10.1586/1744666x.2013.850030
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Genome Engineering at the Dawn of the Golden Age
- (2013) David J. Segal et al. Annual Review of Genomics and Human Genetics
- Development of gene therapy for blood disorders: an update
- (2013) A. W. Nienhuis BLOOD
- A Phenotypic Approach for IUIS PID Classification and Diagnosis: Guidelines for Clinicians at the Bedside
- (2013) Ahmed Aziz Bousfiha et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Gene therapy clinical trials worldwide to 2012 - an update
- (2013) Samantha L. Ginn et al. JOURNAL OF GENE MEDICINE
- Splicing therapy for neuromuscular disease
- (2013) Andrew G.L. Douglas et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Genomic Editing of the HIV-1 Coreceptor CCR5 in Adult Hematopoietic Stem and Progenitor Cells Using Zinc Finger Nucleases
- (2013) Lijing Li et al. MOLECULAR THERAPY
- Fyn Kinase Is Required for Optimal Humoral Responses
- (2013) Natalia S. Chaimowitz et al. PLoS One
- RNA-Guided Human Genome Engineering via Cas9
- (2013) P. Mali et al. SCIENCE
- Multiplex Genome Engineering Using CRISPR/Cas Systems
- (2013) L. Cong et al. SCIENCE
- Evaluating risks of insertional mutagenesis by DNA transposons in gene therapy
- (2013) Perry B. Hackett et al. Translational Research
- Targeting RNA splicing for disease therapy
- (2013) Mallory A. Havens et al. Wiley Interdisciplinary Reviews-RNA
- Induced pluripotent stem cells in clinical hematology
- (2012) Athanasia D. Panopoulos et al. CURRENT OPINION IN HEMATOLOGY
- Recent developments in transposon-mediated gene therapy
- (2012) Mario Di Matteo et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Zinc-finger nuclease-mediated gene correction using single AAV vector transduction and enhancement by Food and Drug Administration-approved drugs
- (2012) B L Ellis et al. GENE THERAPY
- Precision genome engineering with programmable DNA-nicking enzymes
- (2012) E. Kim et al. GENOME RESEARCH
- An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects
- (2012) Eugenio Fernandez Alanis et al. HUMAN MOLECULAR GENETICS
- Agammaglobulinemia and absent B lineage cells in a patient lacking the p85α subunit of PI3K
- (2012) Mary Ellen Conley et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Alpharetroviral Self-inactivating Vectors: Long-term Transgene Expression in Murine Hematopoietic Cells and Low Genotoxicity
- (2012) Julia D Suerth et al. MOLECULAR THERAPY
- The promise of induced pluripotent stem cells in research and therapy
- (2012) Daisy A. Robinton et al. NATURE
- Cold Urticaria, Immunodeficiency, and Autoimmunity Related toPLCG2Deletions
- (2012) Michael J. Ombrello et al. NEW ENGLAND JOURNAL OF MEDICINE
- Akt and mTOR in B Cell Activation and Differentiation
- (2012) Jose J. Limon et al. Frontiers in Immunology
- Agammaglobulinemia associated with BCR- B cells and enhanced expression of CD19
- (2011) A. K. Dobbs et al. BLOOD
- IL-7R expression and IL-7 signaling confer a distinct phenotype on developing human B-lineage cells
- (2011) S. E. Nodland et al. BLOOD
- Epigenetic Memory and Preferential Lineage-Specific Differentiation in Induced Pluripotent Stem Cells Derived from Human Pancreatic Islet Beta Cells
- (2011) Ori Bar-Nur et al. Cell Stem Cell
- Key aspects for successful immunoglobulin therapy of primary immunodeficiencies
- (2011) C. Cunningham-Rundles CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Blk haploinsufficiency impairs the development, but enhances the functional responses, of MZ B cells
- (2011) Elizabeth M Samuelson et al. IMMUNOLOGY AND CELL BIOLOGY
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Regulation of BCR signaling
- (2011) Tomohiro Kurosaki MOLECULAR IMMUNOLOGY
- Immunogenicity of induced pluripotent stem cells
- (2011) Tongbiao Zhao et al. NATURE
- In vivo genome editing restores haemostasis in a mouse model of haemophilia
- (2011) Hojun Li et al. NATURE
- Genetic engineering of human pluripotent cells using TALE nucleases
- (2011) Dirk Hockemeyer et al. NATURE BIOTECHNOLOGY
- Site-specific integration and tailoring of cassette design for sustainable gene transfer
- (2011) Angelo Lombardo et al. NATURE METHODS
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design principles for bifunctional targeted oligonucleotide enhancers of splicing
- (2011) N. Owen et al. NUCLEIC ACIDS RESEARCH
- Compensatory signals associated with the activation of human GC 5′ splice sites
- (2011) Jana Kralovicova et al. NUCLEIC ACIDS RESEARCH
- Targeted Genome Editing Across Species Using ZFNs and TALENs
- (2011) Andrew J. Wood et al. SCIENCE
- B cell-specific lentiviral gene therapy leads to sustained B-cell functional recovery in a murine model of X-linked agammaglobulinemia
- (2010) H. M. Kerns et al. BLOOD
- Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells
- (2010) Yoav Mayshar et al. Cell Stem Cell
- Correction of B-cell development in Btk-deficient mice using lentiviral vectors with codon-optimized human BTK
- (2010) Y Y Ng et al. LEUKEMIA
- Development of B-lineage Predominant Lentiviral Vectors for Use in Genetic Therapies for B Cell Disorders
- (2010) Blythe D Sather et al. MOLECULAR THERAPY
- 20 years of gene therapy for SCID
- (2010) Alain Fischer et al. NATURE IMMUNOLOGY
- Primary B Cell Immunodeficiencies: Comparisons and Contrasts
- (2009) Mary Ellen Conley et al. Annual Review of Immunology
- Rescue of coagulation factor VII function by the U1+5A snRNA
- (2009) M. Pinotti et al. BLOOD
- A critical role of TAK1 in B-cell receptor–mediated nuclear factor κB activation
- (2009) James Schuman et al. BLOOD
- Foxo3-/- mice demonstrate reduced numbers of pre-B and recirculating B cells but normal splenic B cell sub-population distribution
- (2009) R. M. Hinman et al. INTERNATIONAL IMMUNOLOGY
- Gross Deletions Involving IGHM, BTK, or Artemis: A Model for Genomic Lesions Mediated by Transposable Elements
- (2008) Menno C. van Zelm et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Development of an enhanced B-specific lentiviral vector expressing BTK: a tool for gene therapy of XLA
- (2008) T Moreau et al. GENE THERAPY
- Erk Kinases Link Pre-B Cell Receptor Signaling to Transcriptional Events Required for Early B Cell Expansion
- (2008) Tomoharu Yasuda et al. IMMUNITY
- Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation
- (2008) Hart S Dengler et al. NATURE IMMUNOLOGY
- Characterization of Bruton's tyrosine kinase mutations in Mexican patients with X-linked agammaglobulinemia
- (2007) G. Lopez-Herrera et al. MOLECULAR IMMUNOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now